Table 3.

Proportion of Papillary Thyroid Microcarcinomas by Exposure for All Chart-Adjudicated Cases

	No. of Cases Exposed	PTMC ≤10 mm (N = 33)	%	95% CI
All Comparator Drugs	63	27	43	31–56
Liraglutide	9	6	67	31–91
Exenatide	2	1	50	3–97
DPP-4 Inhibitors (Sitagliptin/Saxagliptin/Linagliptin)	4	1	25	1–78
Metformin	37	16	43	28–60
Sulfonylureas (Glyburide/Glipizide/Glimepiride)	14	6	43	19–70
Pioglitazone	6	3	50	14–86

Abbreviations: PTMC, papillary thyroid microcarcinoma; mm, millimeters; CI, confidence interval; DPP, dipeptidyl peptidase-4.